Viability and Burden of Leishmania in Extralesional Sites during Human Dermal Leishmaniasis
Open Access
- 14 September 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 4 (9) , e819
Abstract
The clinical and epidemiological significance of Leishmania DNA in extralesional sites is obscured by uncertainty of whether the DNA derives from viable parasites. To examine dissemination of Leishmania during active disease and the potential participation of human infection in transmission, Leishmania 7SLRNA was exploited to establish viability and estimate parasite burden in extralesional sites of dermal leishmaniasis patients. The feasibility of discriminating parasite viability by PCR of Leishmania 7SLRNA was evaluated in relation with luciferase activity of luc transfected intracellular amastigotes in dose-response assays of Glucantime cytotoxicity. Monocytes, tonsil swabs, aspirates of normal skin and lesions of 28 cutaneous and 2 mucocutaneous leishmaniasis patients were screened by kDNA amplification/Southern blot. Positive samples were analyzed by quantitative PCR of Leishmania 7SLRNA genes and transcripts. 7SLRNA amplification coincided with luciferase activity, confirming discrimination of parasite viability. Of 22 patients presenting kDNA in extralesional samples, Leishmania 7SLRNA genes or transcripts were detected in one or more kDNA positive samples in 100% and 73% of patients, respectively. Gene and transcript copy number amplified from extralesional tissues were comparable to lesions. 7SLRNA transcripts were detected in 13/19 (68%) monocyte samples, 5/12 (42%) tonsil swabs, 4/11 (36%) normal skin aspirates, and 22/25 (88%) lesions; genes were quantifiable in 15/19 (79%) monocyte samples, 12/13 (92%) tonsil swabs, 8/11 (73%) normal skin aspirates. Viable parasites are present in extralesional sites, including blood monocytes, tonsils and normal skin of dermal leishmaniasis patients. Leishmania 7SLRNA is an informative target for clinical and epidemiologic investigations of human leishmaniasis. Understanding of the dynamics and distribution of Leishmania in the human host is fundamental to the targeting of control measures and their evaluation. Amplification of parasite gene sequences in clinical samples from cutaneous leishmaniasis patients has provided evidence of Leishmania in blood, other tissues and sites distinct from the lesion and of persistence of infection after clinical resolution of disease. However, there is uncertainty about the interpretation of the presence of Leishmania DNA as indicative of viable parasites. Because RNA is short-lived and labile, its presence provides an indicator of viability. We amplified Leishmania 7SLRNA, a molecule involved in intracellular protein translocation, to establish viability and estimate parasite load in blood monocytes, tonsil swab samples, and tissue fluid from healthy skin of patients with dermal leishmaniasis. Results showed that during active dermal leishmaniasis, viable Leishmania are present in blood monocytes, tonsils and normal skin in quantities similar to that in lesions, demonstrating widespread dissemination of infection and subclinical involvement of tissues beyond the lesion site. Leishmania 7SLRNA will be useful in deciphering the role of human infection in transmission.Keywords
This publication has 24 references indexed in Scilit:
- Detection ofLeishmaniain Unaffected Mucosal Tissues of Patients with Cutaneous Leishmaniasis Caused byLeishmania (Viannia)SpeciesThe Journal of Infectious Diseases, 2009
- Comparison between Quantitative Nucleic Acid Sequence-Based Amplification, Real-Time Reverse Transcriptase PCR, and Real-Time PCR for Quantification ofLeishmaniaParasitesJournal of Clinical Microbiology, 2008
- Real-Time Reverse Transcription-PCR for Transcriptional Expression Analysis of Virulence and Housekeeping Genes in Viable but NonculturableVibrio parahaemolyticusafter Recovery of CulturabilityApplied and Environmental Microbiology, 2007
- Comparative genomic analysis of three Leishmania species that cause diverse human diseaseNature Genetics, 2007
- Evidence forLeishmania (Viannia)Parasites in the Skin and Blood of Patients Before and After TreatmentThe Journal of Infectious Diseases, 2006
- SELECTIVE ACTION OF FLUOROQUINOLONES AGAINST INTRACELLULAR AMASTIGOTES OF LEISHMANIA (VIANNIA) PANAMENSIS IN VITROJournal of Parasitology, 2005
- Induced structural changes of 7SL RNA during the assembly of human signal recognition particleNature Structural & Molecular Biology, 2002
- Cutaneous Leishmaniasis following Local Trauma: A Clinical PearlClinical Infectious Diseases, 2000
- Detection ofLeishmaniaDNA by Polymerase Chain Reaction in Scars of Treated Human PatientsThe Journal of Infectious Diseases, 1998
- The 7SL RNA homologue of Trypanosoma brucei is closely related to mammalian 7SL RNAMolecular and Biochemical Parasitology, 1992